A Trial of RAD001/Capecitabine in Refractory Gastric Cancer

Clinical trial NCT01099527 · COMPLETED

Trial details

NCT number: NCT01099527
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Gastric Cancer

Start date: 2009-10-01
Primary completion: 2013-08-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.